Arcus Biosciences (RCUS) Asset Utilization Ratio (2018 - 2026)

Arcus Biosciences' Asset Utilization Ratio history runs 9 years deep, the most recent figure standing at 0.22 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio rose 84.14% year-over-year to 0.22 in Q1 2026; TTM through Mar 2026 was 0.22, a 84.14% increase from a year earlier, with the FY2025 full-year figure at 0.22, down 6.1% from the prior year.
• Asset Utilization Ratio fell to 0.22 in Q1 2026 per RCUS's latest filing, from 0.23 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.3 in Q3 2022 and bottomed at 0.08 in Q4 2022.
• The 5-year median for Asset Utilization Ratio is 0.2 (2024), against an average of 0.18.
• Biggest YoY gain for Asset Utilization Ratio was 591.67% in 2022; the steepest drop was 73.61% in 2022.
• Year by year, Asset Utilization Ratio stood at 0.08 in 2022, then rose by 5.21% to 0.09 in 2023, then soared by 140.73% to 0.21 in 2024, then advanced by 11.01% to 0.23 in 2025, then retreated by 5.48% to 0.22 in 2026.
• Per Business Quant, the three latest RCUS Asset Utilization Ratio figures stand at 0.22 (Q1 2026), 0.23 (Q4 2025), and 0.23 (Q3 2025).